Latus Pharma ApS — Credit Rating and Financial Key Figures
CVR number: 36974214
Birkevej 4, Strøby Egede 4600 Køge
jwi@latuspharma.com
tel: 71725955
www.latuspharma.com
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | -6.90 | ||||
| Other operating income | 0.36 | ||||
| Gross profit | -3.92 | -4.11 | -13.68 | -10.81 | -6.90 |
| Costs of management | -3.92 | -4.11 | -13.68 | -11.18 | |
| EBIT | -3.92 | -4.11 | -13.68 | -10.81 | -6.90 |
| Pre-tax profit | -3.92 | -4.11 | -13.68 | -10.81 | -6.90 |
| Net earnings | -3.92 | -4.11 | -13.68 | -10.81 | -6.90 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | -2.94 | ||||
| Long term receivables total | |||||
| Inventories total | |||||
| Current other receivables | 0.94 | 0.32 | 0.40 | 1.64 | 0.24 |
| Current deferred tax assets | 2.00 | ||||
| Short term receivables total | 2.94 | 0.32 | 0.40 | 1.64 | 0.24 |
| Cash and bank deposits | 122.84 | 118.41 | 104.65 | 92.60 | 88.25 |
| Cash and cash equivalents | 122.84 | 118.41 | 104.65 | 92.60 | 88.25 |
| Balance sheet total (assets) | 122.84 | 118.73 | 105.05 | 94.24 | 88.48 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Other reserves | 76.76 | 72.84 | 68.73 | 55.05 | 45.38 |
| Profit of the financial year | -3.92 | -4.11 | -13.68 | -10.81 | -6.90 |
| Shareholders equity total | 122.84 | 118.73 | 105.05 | 94.24 | 88.48 |
| Non-current liabilities total | |||||
| Current liabilities total | |||||
| Balance sheet total (liabilities) | 122.84 | 118.73 | 105.05 | 94.24 | 88.48 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.